I agree clarity on revenue potential is lacking (and required) in the statement released from Unilife There is clearly potential for significant revenue however as this is not a cheap drug:
(Wikipedia) Cost and Market[edit source | editbeta]
A single 60 mg injection of Enoxaparin can cost $898.00 for the drug alone, as shown in a 2013 statement from a California hospital. Annual sales approx $3.17 billion.[citation needed] Enoxaparin is not protected by US patent due to inequitable conduct on the filing of Patent No. 5,389,618.[4]
UNS Price at posting:
56.0¢ Sentiment: None Disclosure: Held